SNAP-94847
SNAP-94847
|
Systematic (IUPAC) name |
---|
N-(3-[1-([4-(3,4-difluorophenoxy)phenyl]methyl)(4-piperidyl)]-4-methylphenyl)-2-methylpropanamide |
Clinical data |
---|
Identifiers |
---|
Chemical data |
---|
Formula |
C29H32F2N2O2 |
---|
|
478.572 |
---|
SMILES
- Fc1ccc(cc1F)Oc(cc4)ccc4CN(CC3)CCC3c2cc(NC(=O)C(C)C)ccc2C
|
Y (what is this?) (verify) |
---|
SNAP-94847 is a drug used in scientific research, which is a selective, non-peptide antagonist at the melanin concentrating hormone receptor MCH1. In animal studies it has been shown to produce both anxiolytic and antidepressant effects,[1][2] and also reduces food consumption suggesting a possible anorectic effect.[3]
References
- ↑ David DJ, Klemenhagen KC, Holick KA, Saxe MD, Mendez I, Santarelli L, Craig DA, Zhong H, Swanson CJ, Hegde LG, Ping XI, Dong D, Marzabadi MR, Gerald CP, Hen R (April 2007). "Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis". The Journal of Pharmacology and Experimental Therapeutics 321 (1): 237–48. doi:10.1124/jpet.106.109678. PMID 17237257.
- ↑ Smith DG, Hegde LG, Wolinsky TD, Miller S, Papp M, Ping X, Edwards T, Gerald CP, Craig DA (February 2009). "The effects of stressful stimuli and hypothalamic-pituitary-adrenal axis activation are reversed by the melanin-concentrating hormone 1 receptor antagonist SNAP 94847 in rodents". Behavioural Brain Research 197 (2): 284–91. doi:10.1016/j.bbr.2008.08.026. PMID 18793675.
- ↑ Nair SG, Adams-Deutsch T, Pickens CL, Smith DG, Shaham Y (July 2009). "Effects of the MCH1 receptor antagonist SNAP 94847 on high-fat food-reinforced operant responding and reinstatement of food seeking in rats". Psychopharmacology 205 (1): 129–40. doi:10.1007/s00213-009-1523-6. PMC 3143407. PMID 19340414.
|
---|
| CGRP | |
---|
| Cholecystokinin | |
---|
| CRH | |
---|
| Galanin | |
---|
| MCH | | |
---|
| |
- Agonists: Melanin concentrating hormone
|
---|
|
---|
| Melanocortin | | |
---|
| | |
---|
| | |
---|
| | |
---|
| | |
---|
| Unsorted |
- Agonists: Alsactide
- Codactide
- Giractide
- Norleusactide
- Seractide
- Tosactide
- Tricosactide
- Tridecactide
|
---|
|
---|
| Neuropeptide S | |
---|
| Neuropeptide Y | |
---|
| Neurotensin | |
---|
| Opioid | See here instead. |
---|
| Orexin | |
---|
| Oxytocin | |
---|
| Tachykinin | |
- Agonists: Substance P
Antagonists: Aprepitant
- Befetupitant
- Burapitant
- Casopitant
- CI-1021
- CP-96,345
- CP-99,994
- CP-122,721
- Dapitant
- Ezlopitant
- Figopitant
- FK-888
- Fosaprepitant
- GR-203,040
- GW-597,599
- HSP-117
- L-733,060
- L-741,671
- L-743,310
- L-758,298
- Lanepitant
- LY-306,740
- Maropitant
- Netupitant
- NKP-608
- Nolpitantium besilate
- Orvepitant
- Rolapitant
- RP-67,580
- SDZ NKT 343
- Serlopitant
- Telmapitant
- Vestipitant
- Vofopitant
|
---|
| | |
---|
| | |
---|
|
---|
| Vasopressin | |
---|
| See also: Peptidergics |
|
|
---|
| 5-HT1A agonists | |
---|
| GABAAR PAMs | |
---|
| α2δ VDCC blockers | |
---|
| Antidepressants | |
---|
| Sympatholytics | |
---|
| Others | |
---|
| |
---|
| Description | |
---|
| Disorders |
- Mental and behavioral
- Mood
- Developmental
- pervasive
- dyslexia and specific
- Substance-related
- Emotional and behavioral
- Symptoms and signs
- Evaluation and testing
|
---|
| Treatment |
- Psychotherapy
- Drugs
- depression
- antipsychotics
- anxiety
- dementia
- hypnotics and sedatives
- psychostimulants, ADHD and nootropics
|
---|
|
|